VEGFA and neoplasm: demonstrated that VEGF increases RANKL promoter activity in ES, leading to induced bone lysis (Guan et al., 2009), which may explain the increased osteolytic phenotype of ES after CHM1 knockdown in our osteotropic tumor model as observed here.